![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. Harpagophytum Extract Ws 1531
2. Harpagoside-b
3. Ws 1531
4. Ws1531
1. 19210-12-9
2. E-harpagoside
3. 8kgs1dc5zu
4. Chebi:5625
5. [(1s,4as,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (e)-3-phenylprop-2-enoate
6. Smr001233395
7. Unii-8kgs1dc5zu
8. Harpaside
9. Einecs 242-881-6
10. Prestwick3_000988
11. Harpagoside [inci]
12. Bspbio_001055
13. Harpagoside [who-dd]
14. Mls002154086
15. Mls002473324
16. Schembl893387
17. Bpbio1_001161
18. Chembl516702
19. Megxp0_000469
20. Harpagoside, Analytical Standard
21. Acon0_000056
22. Acon1_000134
23. Dtxsid101032528
24. Hms2098e17
25. Hms2231n12
26. Hy-n0396
27. Zinc8214398
28. Mfcd00017415
29. S9171
30. Akos015896715
31. Ccg-269650
32. Lmpr0102070010
33. Ncgc00179325-01
34. Ncgc00179325-02
35. Ncgc00179325-04
36. Ac-34268
37. As-56071
38. Ab00513986
39. Cs-0008931
40. C09783
41. H10494
42. 210h129
43. A880338
44. Q-100231
45. Brd-k07996107-001-01-7
46. Brd-k07996107-001-03-3
47. Harpagoside, Primary Pharmaceutical Reference Standard
48. Q25099323
49. Harpagoside, European Pharmacopoeia (ep) Reference Standard
50. (1s,4as,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl Cinnamate
51. (1s,4as,5r,7s,7as)-4a,5-dihydroxy-7-methyl-1-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl Cinnamate
52. (1s-(1alpha,4aalpha,5alpha,7alpha(e),7aalpha))-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-((allyl-1-oxo-3-phenyl)oxy)cyclopenta(c)pyran-1-yl-beta-d-glucopyranoside
53. .beta.-d-glucopyranoside, (1s,4as,5r,7s,7as)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-(((2e)-1-oxo-3-phenyl-2-propenyl)oxy)cyclopenta(c)pyran-1-yl
54. Ncgc00179325-04_c24h30o11_(1s,4as,5r,7s,7as)-1-(beta-d-glucopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl (2e)-3-phenylacrylate
Molecular Weight | 494.5 g/mol |
---|---|
Molecular Formula | C24H30O11 |
XLogP3 | -0.6 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 7 |
Exact Mass | 494.17881177 g/mol |
Monoisotopic Mass | 494.17881177 g/mol |
Topological Polar Surface Area | 175 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 811 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |